AMRUTANJAN vs APLLTD: Stock Comparison
ALEMBIC PHARMA is the larger company by market capitalisation. AMRUTAJAN HEALTH shows a lower P/E, a higher ROE and faster revenue growth, while ALEMBIC PHARMA shows a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
AMRUTANJAN leads 8; APLLTD leads 5 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | AMRUTANJAN | APLLTD |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceuticals | Pharmaceuticals |
Price
| Metric | AMRUTANJAN | APLLTD |
|---|---|---|
| Live Price | ₹505.45 | ₹808.2 |
| Day Change | -0.37% | 0.57% |
| Volume | 41,069 | 1.74 L |
| 52-Week High | ₹790.95 | ₹998 |
| 52-Week Low | ₹482.8 | ₹635.8 |
| Distance from 52W High | -36.1% | -19.02% |
Valuation
| Metric | AMRUTANJAN | APLLTD |
|---|---|---|
| Market Cap | ₹1,451 Cr | ₹15,837 Cr |
| P/E Ratio | 0x | 23.35x |
| P/B Ratio | 0x | 2.85x |
| EPS | ₹1.51 | ₹10.02 |
| Book Value | ₹128.06 | ₹288.41 |
| Dividend Yield | 0.92% | 1.49% |
Growth
| Metric | AMRUTANJAN | APLLTD |
|---|---|---|
| Revenue Growth (TTM YoY) | 10.5% | 4.4% |
| EPS Growth (TTM YoY) | 6.7% | 29.2% |
| Qtr Sales Growth | -79.51% | -13.1% |
| Qtr Profit Growth | -92.46% | 14.27% |
Profitability & Leverage
| Metric | AMRUTANJAN | APLLTD |
|---|---|---|
| ROE | 15.64% | 11.4% |
| ROCE | 16.18% | 10.99% |
| Net Margin | 11.52% | 8.98% |
| Operating Margin | 15.54% | 11.13% |
| Debt to Equity | 0x | 0.2x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | AMRUTANJAN | APLLTD |
|---|---|---|
| Promoter Holding | 46.52% | 69.36%▲ 0.13 pp |
| FII Holding | 2.44%▲ 0.27 pp | 4.18%▼ 0.07 pp |
| DII Holding | 12.28%▼ 0.38 pp | 15.94%▼ 0.24 pp |
| Public Holding | 38.72%▲ 0.11 pp | 10.01%▲ 0.18 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: AMRUTAJAN HEALTH and ALEMBIC PHARMA.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.